Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis.

Peine, Brian R; Callaghan, Michael U; Callaghan, Joseph H; Glaros, Alexander K

Peine, Brian R; Callaghan, Michael U; Callaghan, Joseph H; Glaros, Alexander K.

Afiliação

Peine BR; Clinical Research Institute, College of Medicine, Central Michigan University, 1280 S. East Campus Dr., Mount Pleasant, MI 48859, USA.
Callaghan MU; Clinical Research Institute, College of Medicine, Central Michigan University, 1280 S. East Campus Dr., Mount Pleasant, MI 48859, USA.
Callaghan JH; Children's Hospital of Michigan, 3901 Beaubien Blvd, Detroit, MI 48201, USA.
Glaros AK; Accounting Program, School of Business Administration, Oakland University, 201 Meadow Brook Road, Rochester, MI 48309, USA.

J Clin Med ; 11(12)2022 Jun 17.

Article em En | MEDLINE | ID: mdl-35743561

Palavras-chave

Hydroxyurea; average maximum mean velocity; ischemic; sickle; stroke; trans cranial doppler

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google